With offices in France (Paris) and in the USA (Princeton, New Jersey), STENTYS became listed on the Paris EuroNext stock exchange (STNT.PA) in October 2010. STENTYS® received CE-Marking for its BMS and DES(P) stents in early 2010 and currently sells its products in more than 8 European countries.
The STENTYS Clinical Program includes both randomised trials and real-life registries, evaluating the STENTYS stent in STEMI with the APPOSITION program, and in bifurcations with the OPEN program. STENTYS has started a 3,000 patient post-market registry in 2012 to examine the real-world use of the STENTYS stent where stent sizing is a concern.

Company Growth (employees)
Paris, FR
Size (employees)
27 (est)
Stentys was founded in 2006 and is headquartered in Paris, FR

Stentys Office Locations

Stentys has offices in Paris, Princeton
Paris, FR
Princeton, US

Stentys Metrics

Stentys Summary

Market capitalization

€36.8 m

Closing share price

Stentys's current market capitalization is €36.8 m.

Stentys Market Value History

Stentys Online Presence

Stentys Company Life

You may also be interested in